ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
Authors
Keywords
ANLN, Prognostic biomarker, Breast cancer, Proliferation, Antibody-based proteomics
Journal
BMC CANCER
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-18
DOI
10.1186/s12885-016-2923-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer
- (2014) Weibing Zhou et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
- (2013) Patrick C O´Leary et al. BMC CANCER
- Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
- (2013) Linn Fagerberg et al. MOLECULAR & CELLULAR PROTEOMICS
- Whole Transcriptome RNA-Seq Analysis of Breast Cancer Recurrence Risk Using Formalin-Fixed Paraffin-Embedded Tumor Tissue
- (2012) Dominick Sinicropi et al. PLoS One
- Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas
- (2012) Caroline Kampf et al. Jove-Journal of Visualized Experiments
- St. Gallen 2011: Summary of the Consensus Discussion
- (2011) Michael Gnant et al. Breast Care
- Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice
- (2011) Moshe Elkabets et al. JOURNAL OF CLINICAL INVESTIGATION
- The Human Protein Atlas as a proteomic resource for biomarker discovery
- (2011) F. Pontén et al. JOURNAL OF INTERNAL MEDICINE
- Generation of monospecific antibodies based on affinity capture of polyclonal antibodies
- (2011) Barbara Hjelm et al. PROTEIN SCIENCE
- Tamoxifen and its New Derivatives in Cancer Research
- (2011) Claudia Rivera-Guevara et al. Recent Patents on Anti-Cancer Drug Discovery
- The myriad roles of Anillin during cytokinesis
- (2010) Alisa J. Piekny et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- NBL1 and anillin (ANLN) genes over-expression in pancreatic carcinoma.
- (2009) Marek Olakowski et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung
- (2008) M. Skrzypski et al. CLINICAL CANCER RESEARCH
- A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer
- (2008) M. Chanrion et al. CLINICAL CANCER RESEARCH
- Anillin Is a Scaffold Protein That Links RhoA, Actin, and Myosin during Cytokinesis
- (2008) Alisa J. Piekny et al. CURRENT BIOLOGY
- Rho-dependent control of anillin behavior during cytokinesis
- (2008) Gilles R.X. Hickson et al. JOURNAL OF CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now